Publications
Detailed Information
The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start?
Cited 41 time in
Web of Science
Cited 45 time in Scopus
- Authors
- Issue Date
- 2009-11-30
- Publisher
- ELSEVIER SCIENCE BV
- Citation
- ADVANCED DRUG DELIVERY REVIEWS; Vol.61 14; 1316-1323
- Keywords
- Neuroprotection ; Alzheimer`s disease ; Parkinson`s disease ; Therapeutics ; Huntington`s disease ; Amyotrophic lateral sclerosis
- Abstract
- Mitochondria are the power engine generating biochemical energy in the cell. Mitochondrial dysfunction and bioenergy deficiency is closely linked to the pathogenesis of neurodegenerative disorders. Mitochondria play a variety of roles by integrating extracellular signals and executing important intracellular events in neuronal survival and death. in this context, the regulation of mitochondrial function via therapeutic approaches may exert some salutary and neuroprotective mechanisms. Understanding the relationship of mitochondria-dependent pathogenesis may provide important pharmacological utility in the treatment of neurodegenerative conditions such as Alzheimer`s disease, amyotrophic lateral sclerosis, Huntington`s disease and Parkinson`s disease. Indeed, the modulation of mitochondrial pathways is rapidly emerging as a novel therapeutic target. This review focuses on how mitochondria are involved in neurodegeneration and what therapeutics are available to target mitochondrial pathways. (C) 2009 Elsevier B.V. All rights reserved.
- ISSN
- 0169-409X
- Language
- English
- Files in This Item:
- There are no files associated with this item.
- Appears in Collections:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.